Skip to main content
. 2017 Jun 29;165(3):573–583. doi: 10.1007/s10549-017-4358-6

Fig. 5.

Fig. 5

DFS by central Ki-67 expression levels in centrally HR+ patients. DFS in the triple-negative (centrally ER/PR/HER2-negative) subgroup is included for comparison